• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.

作者信息

Spyropoulos A C, Douketis J D, Gerotziafas G, Kaatz S, Ortel T L, Schulman S

机构信息

Department of Medicine, Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

J Thromb Haemost. 2012 Apr;10(4):692-4. doi: 10.1111/j.1538-7836.2012.04630.x.

DOI:10.1111/j.1538-7836.2012.04630.x
PMID:22934291
Abstract
摘要

相似文献

1
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.围手术期抗栓和桥接治疗：慢性口服抗凝治疗动脉适应症患者标准化报告的建议
J Thromb Haemost. 2012 Apr;10(4):692-4. doi: 10.1111/j.1538-7836.2012.04630.x.
2
[New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].[新型口服抗凝药——华法林在房颤治疗中的落幕]
Kardiol Pol. 2012;70(10):1053-60.
3
New oral anticoagulant agents - general features and outcomes in subsets of patients.新型口服抗凝剂——患者亚组的一般特征及转归
Thromb Haemost. 2014 Apr 1;111(4):575-82. doi: 10.1160/TH13-09-0803. Epub 2014 Jan 23.
4
Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory.非维生素K拮抗剂口服抗凝药（NOACs）：实验室视角
Br J Biomed Sci. 2014;71(4):158-67. doi: 10.1080/09674845.2014.11669981.
5
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.心脏病患者页面。心房颤动患者服用非维生素K拮抗剂口服抗凝剂的指南。
Circulation. 2015 Apr 21;131(16):e412-5. doi: 10.1161/CIRCULATIONAHA.114.012808.
6
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.依度沙班与达比加群、利伐沙班及阿哌沙班相比在预防心房颤动患者卒中方面的疗效和安全性：一项间接比较分析
Thromb Haemost. 2014 May 5;111(5):981-8. doi: 10.1160/TH14-02-0118. Epub 2014 Feb 28.
7
Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.直接口服抗凝剂治疗急性静脉血栓栓塞症：系统评价和荟萃分析。
Thromb Res. 2014 Oct;134(4):774-82. doi: 10.1016/j.thromres.2014.06.020. Epub 2014 Jul 6.
8
Direct oral anticoagulants in atrial fibrillation.心房颤动的直接口服抗凝剂。
Semin Hematol. 2014 Apr;51(2):139-46. doi: 10.1053/j.seminhematol.2014.04.001. Epub 2014 Apr 8.
9
Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.新型口服抗凝药不同适应症的大出血风险：来自对50项随机试验批准剂量的荟萃分析的见解
Int J Cardiol. 2015 Jan 20;179:279-87. doi: 10.1016/j.ijcard.2014.11.101. Epub 2014 Nov 13.
10
Bleeding and antidotes in new oral anticoagulants.新型口服抗凝药物的出血与解毒。
Best Pract Res Clin Haematol. 2013 Jun;26(2):191-202. doi: 10.1016/j.beha.2013.07.001. Epub 2013 Jul 21.

引用本文的文献

1
Oral anticoagulant periprocedural management in patients undergoing an oral, dental implant or periodontal surgery: a prospective national observational survey.接受口腔、牙种植或牙周手术患者的口服抗凝剂围手术期管理：一项全国性前瞻性观察性调查。
Res Pract Thromb Haemost. 2025 Apr 10;9(3):102848. doi: 10.1016/j.rpth.2025.102848. eCollection 2025 Mar.
2
Attitude and practice of dentists in patients taking oral antiplatelet and anticoagulant medications.牙科医生对服用口服抗血小板和抗凝药物患者的态度及做法。
BMC Oral Health. 2025 Apr 20;25(1):606. doi: 10.1186/s12903-025-05980-w.
3
Periprocedural Anticoagulation Management of Patients Undergoing Colonoscopy with Polypectomy.
接受结肠镜息肉切除术患者的围手术期抗凝管理
TH Open. 2024 Jun 3;8(2):e216-e223. doi: 10.1055/s-0044-1787553. eCollection 2024 Apr.
4
Impact of perioperative low-molecular-weight heparin therapy on clinical events of elderly patients with prior coronary stents implanted > 12 months undergoing non-cardiac surgery: a randomized, placebo-controlled trial.围手术期低分子量肝素治疗对既往冠状动脉支架植入超过12个月的老年患者行非心脏手术临床事件的影响：一项随机、安慰剂对照试验。
BMC Med. 2024 Apr 23;22(1):171. doi: 10.1186/s12916-024-03391-2.
5
Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices.连续血流左心室辅助装置患者中断抗凝治疗的影响。
J Artif Organs. 2023 Dec;26(4):275-286. doi: 10.1007/s10047-022-01367-8. Epub 2022 Oct 8.
6
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.动脉血栓栓塞高危患者的术后低分子量肝素桥接治疗（PERIOP2）：双盲随机对照试验
BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
7
Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.静脉血栓栓塞症患者围手术期桥接治疗：系统评价。
Am J Med. 2019 Jun;132(6):722-732.e7. doi: 10.1016/j.amjmed.2019.01.004. Epub 2019 Jan 16.
8
Safety of laparoscopic surgery in digestive diseases with special reference to antithrombotic therapy: A systematic review of the literature.消化疾病腹腔镜手术的安全性，特别是抗血栓治疗：文献系统综述
World J Clin Cases. 2018 Nov 26;6(14):767-775. doi: 10.12998/wjcc.v6.i14.767.
9
[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].[接受维生素K拮抗剂治疗患者的桥接抗凝：现状]
Internist (Berl). 2018 Jul;59(7):744-752. doi: 10.1007/s00108-018-0447-9.
10
[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].[接受维生素K拮抗剂治疗患者的桥接抗凝：现状]
Anaesthesist. 2018 Aug;67(8):599-606. doi: 10.1007/s00101-018-0463-0.